Skip to main content
Clinical Trials/NCT04891328
NCT04891328
Completed
N/A

The Experience of Participating in a Pediatric Summer Intensive Therapy Program--A Mixed Methods Study

University of Missouri-Columbia1 site in 1 country13 target enrollmentMay 24, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Neurodevelopmental Disorders
Sponsor
University of Missouri-Columbia
Enrollment
13
Locations
1
Primary Endpoint
Semi-structured interviews
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.

Detailed Description

The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Research questions include: 1.) What are the perceptions of children and caregivers about intensive therapy after participating in multiple intensive therapy episodes over time? 2.) Why do caregivers choose to continue with an intensive model of therapy periodically for their child with neurodevelopmental diagnoses? 3.) What were the outcomes for children with neurodevelopmental disabilities participating in an episode of intensive therapy? Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.

Registry
clinicaltrials.gov
Start Date
May 24, 2021
End Date
October 1, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jamie Hall

Assistant Teaching Professor

University of Missouri-Columbia

Eligibility Criteria

Inclusion Criteria

  • Children receiving therapy through the Children's Therapy Center's Tiger Intensive Program and their caregivers from May 24 to August 13 2021.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Semi-structured interviews

Time Frame: at discharge assessed up to 10 days

Upon completion of the program, children and caregivers will participate in an interview about their experience

Canadian Occupational Performance Measure

Time Frame: measured at discharge 4 weeks after enrollment

Individualized client-centered performance measure

Secondary Outcomes

  • Change in Thomas Test(Measured at day 1 and discharge 4 weeks later)
  • Change in Lower extremity passive range of motion(Measured at day 1 and discharge 4 weeks later)
  • Change in Kids Bestest(Measured at day 1 and discharge 4 weeks later)
  • Change in Timed Up and Down Stairs(Measured at day 1 and discharge 4 weeks later)
  • Change in Peds QL(Measured at day 1 and discharge 4 weeks later)
  • Change in Early Clinical Assessment of Balance(Measured at day 1 and discharge 4 weeks later)
  • Change in Segmental Assessment of Trunk Control (SATCO)(Measured at day 1 and discharge 4 weeks later)
  • Change in Timed on and off the floor(Measured at day 1 and discharge 4 weeks later)
  • Change in popliteal angle(Measured at day 1 and discharge 4 weeks later)
  • Change in m-CTSIB(Measured at day 1 and discharge 4 weeks later)
  • Change in 6 minute walk test(Measured at day 1 and discharge 4 weeks later)
  • Change in GOAL(Measured at day 1 and discharge 4 weeks later)
  • Pediatric Balance Scale(Measured at day 1 and discharge 4 weeks later)
  • Change in Gastrocnemius muscle length(Measured at day 1 and discharge 4 weeks later)
  • Change in Pediatric Evaluation of Disability Inventory(Measured at day 1 and discharge 4 weeks later)
  • Change in Edinburgh Visual Gait Scale(Measured at day 1 and discharge 4 weeks later)

Study Sites (1)

Loading locations...

Similar Trials